After decades of stalled progress, a new wave of clinical research involving psychedelic compounds shows promising results for treating depression, addiction, PTSD, and other mental health conditions. Evidence shows that psychedelics given in clinical therapeutic settings can engender mystical experiences akin to those had in spiritual contexts, and that these may be key to improvements in clinical conditions. Psychiatry and traditional psychodynamic therapy have traditionally been dismissive of the value of religion and spiritual practices, but as psychedelic therapists grapple with valuing this experience and the new orientation to healing it requires, contemplative practices serve as a rich model. This presentation will explore the potential value of psychedelic-assisted therapy providers having a personal contemplative practice as they work with patients undergoing these profound experiences.
Audience members will be invited to submit questions for a Q&A session after the talk.
Tickets are available by donation. Proceeds support the reopening of Menla, the retreat center of the Tibet House, where Fluence retreat programs are regularly held.